Condition
IgA Glomerulonephritis clinical trials and research
As of November 12, 2026, Find a Trial lists 2 IgA Glomerulonephritis clinical trials that are recruiting, at sites in 2 countries (most in China (1), India (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Early budesonide capsules plus standard care for IgA nephropathy
This study tests whether adding budesonide enteric-coated capsules alongside routine blood pressure and glucose-lurine control helps reduce protein in adults with primary IgA nephropathy.
-
Which approved add-on drugs slow kidney decline in South-Asian adults with biopsy-proven IgA nephropathy?
This trial will test whether adding one of several approved oral medications to standard care can slow kidney function loss over two years in South-Asian adults with biopsy-proven IgA nephropathy.
Related topics
Quick answers
How many IgA Glomerulonephritis clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.